Tomonobu Nakamura

Impact of primary kidney disease on the effects of empagliflozin in patients with chronic kidney disease: secondary analyses of the EMPA-KIDNEY trial

PK Judge, Natalie Staplin, KJ Mayne et al. · The Lancet Diabetes & Endocrinology · 2023 · 108 citations · Full text

Medicine, Nephrology, Pharmacotherapy +11

Involvement of a Dysfunctional Dopamine-D1/N-Methyl-d-aspartate-NR1 and Ca2+/Calmodulin-Dependent Protein Kinase II Pathway in the Impairment of Latent Learning in a Model of Schizophrenia Induced by Phencyclidine

Akihiro Mouri, Yukihiro Noda, Akihiro Noda et al. · Molecular Pharmacology · 2007 · 95 citations

Medicine, Neuroscience, Psychiatry +13

Effects of empagliflozin on progression of chronic kidney disease: a prespecified secondary analysis from the empa-kidney trial

Natalie Staplin, Richard Haynes, PK Judge et al. · The Lancet Diabetes & Endocrinology · 2023 · 90 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +14

AFM studies of interaction forces between surfaces in alcohol–water solutions

Yoichi Kanda, Tomonobu Nakamura, Ko Higashitani · Colloids and Surfaces A Physicochemical and Engineering Aspects · 1998 · 70 citations

Natural Sciences, Biophysics, Chemistry +16

Acute thrombotic thrombocytopenic purpura after pneumococcal vaccination

Yuki Kojima, Haruhiko Ohashi, Tomonobu Nakamura et al. · Blood Coagulation & Fibrinolysis · 2014 · 39 citations

Life Sciences, Hematology, Immunology +10